⁍ Merck & Co Inc on Tuesday reported a 54.7% rise in third-quarter profit.
⁍ The company’s net income rose to $2.94 billion, or $1.16 per share, in the third quarter.
– Drugmaker Merck & Co reported a 54.7% rise in third-quarter profit on Tuesday, helped by strong sales of blockbuster cancer drug Keytruda and rebound in sales of its key drugs. The company’s net income rose to $2.94 billion, or $1.16 per share, in the third quarter ended Sept. 30, from $1.90 billion, or $0.74 per share, a year earlier. The company’s net income rose to $2.94 billion, or $1.16 per share, in the third quarter ended Sept. 30, from $1.90 billion, or $0.74 per share, a year earlier.
Source: https://www.reuters.com/article/merck-co-results/merck-quarterly-profit-rises-nearly-55-as-key-drug-sales-rebound-idUSL4N2HI2VZ